These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34015411)

  • 1. Obscurin: A multitasking giant in the fight against cancer.
    Guardia T; Eason M; Kontrogianni-Konstantopoulos A
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188567. PubMed ID: 34015411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer.
    Tuntithavornwat S; Shea DJ; Wong BS; Guardia T; Lee SJ; Yankaskas CL; Zheng L; Kontrogianni-Konstantopoulos A; Konstantopoulos K
    Cancer Lett; 2022 Feb; 526():155-167. PubMed ID: 34826548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling obscurins in heart disease.
    Grogan A; Kontrogianni-Konstantopoulos A
    Pflugers Arch; 2019 May; 471(5):735-743. PubMed ID: 30099631
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Guardia T; Zhang Y; Thompson KN; Lee SJ; Martin SS; Konstantopoulos K; Kontrogianni-Konstantopoulos A
    Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2215553120. PubMed ID: 36877839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
    Shriver M; Stroka KM; Vitolo MI; Martin S; Huso DL; Konstantopoulos K; Kontrogianni-Konstantopoulos A
    Oncogene; 2015 Aug; 34(32):4248-59. PubMed ID: 25381817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.
    Perry NA; Shriver M; Mameza MG; Grabias B; Balzer E; Kontrogianni-Konstantopoulos A
    FASEB J; 2012 Jul; 26(7):2764-75. PubMed ID: 22441987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obscurins: unassuming giants enter the spotlight.
    Perry NA; Ackermann MA; Shriver M; Hu LY; Kontrogianni-Konstantopoulos A
    IUBMB Life; 2013 Jun; 65(6):479-86. PubMed ID: 23512348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obscurins: Goliaths and Davids take over non-muscle tissues.
    Ackermann MA; Shriver M; Perry NA; Hu LY; Kontrogianni-Konstantopoulos A
    PLoS One; 2014; 9(2):e88162. PubMed ID: 24516603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular calcium current disorder and disease phenotype in
    Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
    Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency.
    Marston S; Montgiraud C; Munster AB; Copeland O; Choi O; Dos Remedios C; Messer AE; Ehler E; Knöll R
    PLoS One; 2015; 10(9):e0138568. PubMed ID: 26406308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit.
    Shriver M; Marimuthu S; Paul C; Geist J; Seale T; Konstantopoulos K; Kontrogianni-Konstantopoulos A
    Oncotarget; 2016 Jul; 7(29):45414-45428. PubMed ID: 27323778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis.
    Zemorshidi F; Töpf A; Claeys KG; McFarlane A; Patton A; Nafissi S; Straub V
    Neuromuscul Disord; 2024 Jan; 34():83-88. PubMed ID: 38159459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Intracellular Ca
    Pierantozzi E; Szentesi P; Paolini C; Dienes B; Fodor J; Oláh T; Colombini B; Rassier DE; Rubino EM; Lange S; Rossi D; Csernoch L; Bagni MA; Reggiani C; Sorrentino V
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells.
    Perry NA; Vitolo MI; Martin SS; Kontrogianni-Konstantopoulos A
    Oncotarget; 2014 Sep; 5(18):8558-68. PubMed ID: 25261370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of obscurin immunoglobulin domains Ig58/59 leads to age-dependent cardiac remodeling and arrhythmia.
    Grogan A; Coleman A; Joca H; Granzier H; Russel MW; Ward CW; Kontrogianni-Konstantopoulos A
    Basic Res Cardiol; 2020 Sep; 115(6):60. PubMed ID: 32910221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive genomic meta-analysis identifies confirmatory role of
    Rajendran BK; Deng CX
    Oncotarget; 2017 Nov; 8(60):102263-102276. PubMed ID: 29254242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer.
    Liu Z; Wang L; Guo C; Liu L; Jiao D; Sun Z; Wu K; Zhao Y; Han X
    J Cell Mol Med; 2021 Apr; 25(7):3239-3251. PubMed ID: 33624434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers.
    Kang L; Sun J; Wen X; Cui J; Wang G; Hoffman AR; Hu JF; Li W
    Eur J Cancer; 2015 Jan; 51(2):260-70. PubMed ID: 25465188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinase domains of obscurin interact with intercellular adhesion proteins.
    Hu LY; Kontrogianni-Konstantopoulos A
    FASEB J; 2013 May; 27(5):2001-12. PubMed ID: 23392350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.